InvestorsHub Logo
Followers 29
Posts 2802
Boards Moderated 0
Alias Born 12/05/2021

Re: theorysuit post# 669688

Saturday, 02/03/2024 5:34:57 AM

Saturday, February 03, 2024 5:34:57 AM

Post# of 694422

$20B is overly optimistic if only UK approval. You are right though, there is no intention of actually selling this product.

well I think the comparison between Gilead paying 20 billion for Immunomedics is fair. Trodelvy was only in the process of applying for accelerated approval when they were bought. Gilead then went on to make the BLA. Trodelvy for AAA breast cancer is about the same market size as GBM n and r
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News